rizatriptan benzoate- rizatriptan benzoate tablet, orally disintegrating
jubilant cadista pharmaceuticals inc. - rizatriptan benzoate (unii: wr978s7qhh) (rizatriptan - unii:51086hbw8g) - rizatriptan 5 mg - rizatriptanbenzoate orally disintegrating tablets are indicated for the acute treatment ofmigraine with or without aura in adults and in pediatric patients 6 to 17 yearsold. limitations of use - rizatriptan benzoate orally disintegrating tablets should only be used where a clear diagnosis of migraine has been established. if a patient has no response for the first migraine attack treated with rizatriptan benzoate orally disintegrating tablets, the diagnosis of migraine should be reconsidered before rizatriptan benzoate orally disintegrating tablets are administered to treat any subsequent attacks. rizatriptan benzoate orally disintegrating tablets should only be used where a clear diagnosis of migraine has been established. if a patient has no response for the first migraine attack treated with rizatriptan benzoate orally disintegrating tablets, the diagnosis of migraine should be reconsidered before rizatriptan benzoate orally disintegrating tablets are administered to treat any subsequent attacks. - riz
rizatriptan glenmark 10 mg tabletten
rizatriptan glenmark 5 mg tabletten
teva-rizatriptan tablet
teva canada limited - rizatriptan (rizatriptan benzoate) - tablet - 5mg - rizatriptan (rizatriptan benzoate) 5mg - selective serotonin agonists
teva-rizatriptan tablet
teva canada limited - rizatriptan (rizatriptan benzoate) - tablet - 10mg - rizatriptan (rizatriptan benzoate) 10mg - selective serotonin agonists
rizatriptan heumann 5 mg schmelztabletten
rizatriptan heumann 10 mg tabletten
rizatriptan heumann 5 mg tabletten
rizatriptan pharmathen 10 mg schmelztabletten
rizatriptan pharmathen 5 mg tabletten